GlassScriptPhysician profile
Terre Dene Miller
NPI 1841565728
$2,240.92
in general payments reported to CMS, 2019-2025
19 companies · $304 in 2025
The $304 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $272 · 2022: $448 · 2023: $450 · 2024: $768 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,521.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $736.82 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $332.73 | 2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $213.31 | 2021-2025 | |
| Boston Scientific Corporation | $184.21 | 2022-2023 | Watchman Access System, Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $165.59 | 2022-2025 | Jardiance |
| Pfizer INC. | $127.22 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $106.10 | 2024-2025 | Camzyos, Eliquis |
| Stryker Corporation | $67.58 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Irhythm Technologies, INC. | $53.77 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Abbott Laboratories | $48.43 | 2023-2025 | Triclip, Cardiomems |
| Merck Sharp & Dohme LLC | $43.06 | 2023-2025 | Verquvo |
| Philips North America LLC | $39.11 | 2022-2023 | |
| Actelion Pharmaceuticals US, INC. | $22.60 | 2022 | |
| Terumo Medical Corporation | $21.34 | 2024 | Metacross Otw, Angio-Seal, Glidewire |
| United Therapeutics Corporation | $18.71 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $16.68 | 2024 | |
| Celgene Corporation | $14.61 | 2023 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $14.56 | 2024 | Farxiga |
| Bridgebio Pharma, INC. | $14.49 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terre Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.